Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Jazz Pharmaceuticals plc Director's Dealing 2017

Dec 13, 2017

30751_dirs_2017-12-13_b8f68ae9-03be-4963-90e5-28212e76139f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2017-12-11

Reporting Person: Cox Russell J. (EVP & COO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-12-11 Ordinary Shares M 44200 $8.23 Acquired 96263 Direct
2017-12-11 Ordinary Shares M 4867 $46.83 Acquired 101130 Direct
2017-12-11 Ordinary Shares M 1691 $59.13 Acquired 102821 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-12-11 Incentive Stock Option (right to buy) $8.23 M 44200 Disposed 2020-08-24 Ordinary Shares (44200.0) Direct
2017-12-11 Incentive Stock Option (right to buy) $46.83 M 4867 Disposed 2022-08-08 Ordinary Shares (4867.0) Direct
2017-12-11 Incentive Stock Option (right to buy) $59.13 M 1691 Disposed 2023-03-04 Ordinary Shares (1691.0) Direct

Footnotes

F1: Includes 78 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on November 30, 2017.

F2: This incentive stock option is part of an option award granted on August 25, 2010. The ordinary shares subject to the option award vested over 4 years from the vesting commencement date of July 21, 2010, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments thereafter and were fully vested as of July 21, 2014.

F3: This incentive stock option is part of an option award granted on August 9, 2012. The ordinary shares subject to the option award vested over 4 years from the grant date with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter and were fully vested as of August 9, 2016.

F4: This incentive stock option is part of an option award granted on March 5, 2013. The ordinary shares subject to the option award vested over 4 years from the grant date with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter and were fully vested as of March 5, 2017.